Drug Profile
MR 3066
Alternative Names: IP 301; MP 3066Latest Information Update: 28 Oct 1997
Price :
$50
*
At a glance
- Originator Medea Research
- Class Antidementias; Neuroprotectants
- Mechanism of Action Acetylcholine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 28 Oct 1997 Discontinued-Preclinical for Alzheimer's disease in Italy (Unknown route)
- 28 Oct 1997 Discontinued-Preclinical for Alzheimer's disease in USA (Unknown route)
- 17 Jul 1996 New profile